Page 7 - Third Harmonic Bio News Today : Breaking News, Live

A startup plans an IPO to give a shelved Lilly drug another shot

Published: October 19, 2022

BioPharma

Stocks To Watch: Inflation Reads And Bank Earnings To Dominate The Action

Published: October 8, 2022

Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week

Source: seekingalpha.com

Biotech IPO market slowdown continues as third quarter is weakest since 2011

Published: October 5, 2022

Third Harmonic Bio’s stock market debut was the only biotech IPO that crossed the $100 million threshold in the third quarter as the slowdown in IPO activity showed little sign of changing. Small deals continue to represent most of the IPO activity.

Source: medcitynews.com

Acelyrin Raises $300M to Further Growth - San Fernando Valley Business Journal

Published: September 26, 2022

Acelyrin Inc. has raised $300 million in a Series C round to accelerate its treatments for inflammatory diseases.

Source: sfvbj.com

Prime Medicine becomes the next high-profile biotech to test the IPO waters